IL-6 serum levels predict severity and response to Tocilizumab in COVID-19

IL-6 serum levels predict severity and response to Tocilizumab in COVID-19: an observational study:

Publication date: Available online 30 September 2020
Source: Journal of Allergy and Clinical Immunology
Author(s): José María Galván-Román, Sebastián C. Rodríguez-García, Emilia Roy-Vallejo, Ana Marcos-Jiménez, Santiago Sánchez-Alonso, Carlos Fernández-Díaz, Ana Alcaraz-Serna, Tamara Mateu-Albero, Pablo Rodríguez-Cortes, Ildefonso Sánchez-Cerrillo, Laura Esparcia, Pedro Martínez-Fleta, Celia López-Sanz, Ligia Gabrie, Luciana del Campo Guerola, Carmen Suarez, Julio Ancochea, Alfonso Canabal, Patricia Albert, Diego A. Rodríguez-Serrano